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Purpose: To investigate the preferred and actual participation levels of colorectal cancer
patients and their families in treatment decision-making.
Methods: A cross-sectional survey was conducted using a questionnaire administered to
colorectal cancer patients hospitalized in the general surgical wards in two of the upper
first-class hospitals in Beijing between February and July 2013.
Results: A total of 113 questionnaires were analyzed. For the families of colorectal cancer
patients, the concordance rate of their preferred and actual participation levels in treat-
ment decision-making was 60.2% and 62.8% for the patients themselves. Patients with
stoma and male patients preferred a passive role compared to those without stoma and
female patients (x2 ¼ 7.978, p < 0.05; x2 ¼ 9.854, p < 0.05).
Conclusions: Over 40% of colorectal cancer patients preferred a passive role in treatment
decision-making. We suggest that communication between physicians and patients should
be strengthened to accommodate the patient's desired level of involvement.
Copyright © 2014, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Shared decision-making between doctors and patients has
become more frequent in modern medical practices [1]. Dur-
ing this process, physicians and patients share information
and regarding the patient's disease, risks and benefits of
treatment options, personal values and priorities regardingD. Pang).
Nursing Association.
Association. Production
://creativecommons.org/treatment, and ultimately reach an agreement on the treat-
ment to implement [2,3]. Studies have shown that shared
decision-making could provide a number of benefits for pa-
tients, including a greater sense of personal control, more
satisfaction, and better compliance with treatment, and
consequently better outcomes [4,5].
Colorectal cancer is one of the most common gastrointes-
tinal tumors, with increasingmorbidity andmortality over theand hosting by Elsevier (Singapore) Pte Ltd. This is an open access
licenses/by-nc-nd/3.0/).
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treatment can be difficult due to many factors, such as un-
certainty of long-term treatment effects, the number of
treatment options available, concerns of the length of life and
the quality of life. In addition, there is typically a gap between
medical information of doctors and their patients, making the
patient a more passive participant in the process. Recent
studies of colorectal cancer patients have showed a more
passive involvement in the treatment decision-making
compared with other patients, and also found discrepancies
between the preferred roles and actual roles of patients in the
process [7,8]. In China, widespread controversy still exists
whether patients should be encouraged to participate in
treatment decision-making [9,10]. To date, some in-
vestigations from the perspective of physicians have appeared
but still few studies account for the patient perspective [11,12].
This study aimed to compare preferred participation roles to
actual roles and the degree of their concordance during
treatment decision-making in the sample of colorectal cancer
patients just after surgical treatment. These results could
provide the basis for improving medical services, patients'
satisfaction, and treatment compliance.2. Methods
2.1. Subjects
Colorectal cancer patients hospitalized in general surgical
ward in two of the upper first-class hospitals in Beijing from
February to July 2013 after operation were recruited for this
study. Criteria for inclusion were: a minimum age of 18 years
old, diagnosis of colorectal carcinoma by pathological exam-
ination, postoperative patients, and voluntary participation.
We excluded patients with mental disorders, impaired
cognitive function and other serious somatic disease.
2.2. Instruments
The questionnaire administered to patients was of original
design and divided into two sections, including patients'
general information and their participation in treatment de-
cision-making.
2.2.1. General information
This section collected information regarding the patients'
demographics and medical history. The former included pa-
tients' age, gender, education level and so on and was
completed by patients. The medical history section was
completed after review of the patient's medical record,
including disease diagnosis, with/without stoma.
2.2.2. Preferred and actual participation in decision-making
This section of the questionnaire asked the patients for
preferred families' participation levels, actual families' partici-
pation levels, their own preferred participation roles and their
actual participation roles in the treatment decision-making
process. The questions involving families' participation levels
from most to least were listed as 5 choices including “A. fam-
ilies plenipotentiary”, “B. more than themselves”, “C. equalwith themselves”, “D. less than themselves”, “E. not any
participation”. The questions involving patients' participation
roleswere designed based on the Control Preference Scale (CPS)
[13], which was developed by Dr. Degner in 1992. Then Chinese
scholar Xiaolin Xu translated the English version of CPS into
Chinese and validated its psychometric properties, reporting
testeretest reliability was 0.856 [3]. CPS also has 5 choices: “A. I
prefer to leave all decisions regarding treatment to my doctor”;
“B. I prefer that my doctor make the final decision about which
treatment will be used but seriously considers my opinion”; “C.
I prefer that my doctor and I share responsibility for deciding
which treatment is best for me”; “D. I prefer to make the final
decision about my treatment after seriously considering my
doctor's opinion”; “E. I prefer to make the decision about which
treatment I will receive”. If answer A or B was chosen, the pa-
tient demonstrated a passive role in decision making, C indi-
cated a shared role, and D or E indicated an active role. The use
of CPS was authorized by Degner and Xiaolin Xu. Besides, in
consideration of the domestic situation in China, the choice of
families plenipotentiary was added, which stood for patients
completely not involving in the decision making process.
2.3. Data collection
Data was collected from patients on the day of discharge or
one-day prior. Before investigation, the researchers explained
in detail the purpose of this study and obtained informed
consent from all patients. During the questionnaire process,
patients were given unified instruction and clarification if any
questions arose. All questionnaires were retrieved on the spot
after checking. A total of 123 questionnaires administered,
and 113 (91.9%) questionnaires were analyzed after ruling out
the invalid questionnaires.
2.4. Statistical analysis
Data were recorded and analyzed with SPSS 20.0 software
(SPSS Inc., Chicago, IL, USA). Frequency, mean, standard de-
viation, percentage and other indexes were used for descrip-
tive analysis. Concordance rate and Kappa value [14] analyses
were used to demonstrate the degree of congruence between
preferred and actual participation in decision making. The
differences of decision-making participation between
different patients group were analyzed by Chi square test and
Analysis of Variance. All statistical analyses used a signifi-
cance level of 0.05 (two-sided).
2.5. Ethics
This study was approved by the Peking University Biomedical
Ethics Committee. All patients gave their written informed
consent before filling out the questionnaire.3. Results
3.1. Patient characteristics
The 113 participants who completed the questionnaire ranged
in age from 22 to 91 years with a mean age of 62.8 (SD ¼ 15.3)
Table 1 e For patients, preferred and actual families'






Actual families' participation levels Total (%)
A B C D E
A 22 2 5 1 0 30 (26.5)
B 5 12 2 1 0 20 (17.7)
C 4 9 28 2 3 46 (40.7)
D 0 0 0 2 0 2 (1.8)
E 6 3 2 0 4 15 (13.3)
Total (%) 37 (32.7) 26 (23.0) 37 (32.7) 6 (5.3) 7 (6.2) 113 (100.0)
Note: A ¼ families plenipotentiary; B ¼ more than themselves;
C ¼ equal with themselves; D ¼ less than themselves; E ¼ not any
participation.
The concordance rate between preferred and actual families'
participation roles in decision making ¼ (22 þ 12 þ 28 þ 2þ4)/
113 ¼ 60.2%; K ¼ 0.454, p < 0.01.
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years, six patients (5.3%) aged 30e39 years, 15 patients (13.3%)
aged 40e49 years, 25 patients (22.1%) aged 50e59 years, 25
patients (22.1%) aged 60e69 years, 23 patients (20.4%) aged
70e79 years and 17 patients (15.0%) aged 80e92 years. Among
the participants, 8.8% completed primary school or less, 40.7%
completed high school, 50.5% completed college or greater.
The cohort consisted of 57.5%male patients and 42.5% female
patients, 59.3% colon cancer patients and 40.7% rectal cancer
patients, andmore 75.2% patients without stoma and 24.8% of
patients with stoma.
3.2. Participation levels in decision-making
From the perspective of colorectal cancer patients, we
compared their preferred and actual families' participation
levels during decision making process for their patient's
treatment (Table 1), as well as the patient's own preferred and
actual participation levels in the process (Table 2).
3.3. Participation roles of patients with different
characteristics
The relationship between patient parameters (e.g. ages,
gender, education status, disease diagnosis and with or
without stoma) and their families and their own participation
roles were analyzed using the Chi-squared test and AnalysisTable 2 e Patients' preferred and actual participation roles in t






Total (%) 37 (32.8)
The concordance rate between preferred and actual participation roles inof Variance. We identified a significant difference in the
preferred roles of patients with and without stoma (Table 3),
as well as the actual role of female andmale patients (Table 4).4. Discussion
4.1. Family members are important participants in
treatment decision making
During the past several decades, Shared decision-making has
been advocated as an ideal model of physiciansepatient
interaction in clinical settings [15]. However, patients' active
participation in treatment process relies on support and
encouragement from their doctors and family members. In
our study, we found that only 13.3% colorectal cancer patients
prefer “not any participation” of their family members in the
decision making, and meanwhile only 6.2% of patients actu-
ally do not report any family participation, indicating that
family members are important participants in China. From
Chinese cultural tradition, families have always been
perceived as their own core for an individual. Familymembers
will usually face and solve difficulties, including illness,
together with patients to demonstrate strong family bonds
and affections. In addition, in view of patients' poor condition
and in order to alleviate their mental burden, health care
providers prefer to communicate with family members and
jointly make treatment decisions. However, the relative
importance of the “patient autonomy” versus “family agents”
in treatment decisions remains controversial [16,17].
We found that 25.7% of family members of colorectal pa-
tients have more involvement in the actual treatment
decision-making process than they preferred. That is, for
some patients, their families were more involved than they
expected or preferred. This reflects a specific characteristic of
the treatment decision-making process in China. When pa-
tients are diagnosed with a serious disease especially cancer,
their doctors tend to inform the patients family members
rather than patients themselves, and the family decides how
to inform the patient of the diagnosis. In this setting, doctors
may have limited communication with patients, which may
limit patient autonomy and informed consent. These data
also indicate that it is not always beneficial to hide the illness
from the patients for their familymembers, and instead, some
patients would benefit from more knowledge regarding their
diagnosis and treatment. Our study suggests that health care
providers should carefully evaluate their patients' ability andreatment decision making (n ¼ 113).
nts' actual participation roles Total (%)
iary Passive Shared Active
4 2 2 30 (26.5)
32 1 4 47 (41.6)
7 11 6 28 (24.8)
1 0 6 8 (7.1)
44 (38.9) 14 (12.4) 18 (15.9) 113 (100.0)
decision making ¼ (22 þ 32 þ 11 þ 6)/113 ¼ 62.8%; K ¼ 0.476, p < 0.01.
Table 3 e Patients' preferred roles between patient
groups of with or without stoma (n ¼ 113).






7 (25.1) 17 (60.7) 2 (7.1) 2 (7.1) 7.978 0.046*
Without
stoma
13 (27.1) 30 (35.3) 26 (30.5) 6 (7.1)
*p < 0.05.
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process. Moreover, physicians should cater their approach to
the patient's autonomy in order to meet “the best interests of
patients” [18].
4.2. Colorectal cancer patients' participation roles in
decision making
In our study, 26.5% of patients preferred the role of “families
plenipotentiary”, 41.6% of patients preferred a passive role in
decision-making, 24.8% of patients preferred a shared
decision-making process, and 7.1% patients preferred an
active role. The concordance rate between preferred and
actual roles was 62.8%. Singh et al. [19] reviewed and analyzed
surveys of cancer patients' preferred participation roles in
treatment decision making, and found that 25% of patients
preferred the passive role, 49% patients preferred the shared
role, and 26% patients preferred the active role in treatment
decision-making [19]. Despite the inclusion of an additional
category “families plenipotentiary” in our study, we found
that a larger number of Chinese colorectal cancer patients
preferred to play a passive role in treatment decision-making.
We further analyzed the relationships between patients'
clinical characteristics and their participation roles. These
analyses suggest that patients with stoma preferred a passive
role with 60.7% of passive patients having stoma, whereas
only 35.3% of these patients did not have stoma. This may be
partially explained by the role of traditional Chinese culture,
as discussed above. However, patients with stoma are often
emergency cases or suffer from lower rectal tumors, and have
limited treatment options. Therefore, patients with stoma
tend to be more reliant on physicians to design an effective
treatment that maintains adequate quality of life. In addition,
we found that females were more engaged in actual decision-
making than male patients (x2 ¼ 9.854, p < 0.05), which is
consistent with the results from Beaver et al. [20]. This mayTable 4 e Patients' actual roles between patient groups of
different gender (n ¼ 113).




Male 20 (30.8) 30 (46.2) 10 (15.4) 5 (7.6) 9.854 0.020*
Female 17 (35.4) 14 (29.2) 4 (8.3) 13 (27.1)
*p < 0.05.reflect the general tendency for female patients more to
actively ask the doctors about their own condition and treat-
ment information [21]. If they aremore informed, patients can
play a more active role in the treatment decision-making
process. This conclusion suggests that physicians should
provide more medical information, particularly to patients
with stoma and male patients, to encourage them participate
more actively in treatment decision-making.5. Conclusion
In this study, we explore preferred roles, actual roles, and the
extent to which these patients' preferences were met in de-
cision making among colorectal cancer patients just after
surgical treatment. We found that over 40% of colorectal
cancer patients prefer to play a passive participation role in
making their treatment decisions.We identified discrepancies
between the preferred and actual levels of participation of
both patients and their families. In the future clinical work,
health care providers should pay more attention to patients'
preferred roles in treatment decision making, strengthen
communication with the patients and meet their demands of
knowledge related to treatment, and consequently push for-
ward physician-patient shared decision making and promote
their relationship more harmonious.Conflict of interest statement
The authors declare no conflict of interest.r e f e r e n c e s
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